PRE — Prenetics Global Limited
Prenetics Global Limited, an investment holding company, operates as a diagnostics and genetic testing company. Its products include CircleDNA, a consumer genetic testing product; and Circle HealthPod, a rapid detection health monitoring system that allows users to take COVID-19 tests at point-of-care or at home utilizing the nucleic acid amplification test. The company's products also comprise ColoClear, a non-invasive FIT-DNA colorectal cancer screening test; Circle SnapShot, an off-the-shelf at-home blood test; Circle Medical, a diagnostic testing product; and Circle One and F1x/Fem. Prenetics Global Limited was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.
Company profile
- Sector: Healthcare
- Industry: Medical - Diagnostics & Research
- Country: HK
- Exchange: NASDAQ
- Employees: 285
- Website: https://www.prenetics.com
Latest SEC filings for PRE
- 6-K — 2026-07-14
- 20-F/A — 2026-07-02
- 6-K — 2026-06-04
- 6-K — 2026-05-07
- 20-F — 2026-04-30
- 6-K — 2026-03-03
- 6-K — 2026-02-17
- 6-K — 2026-01-06
- 6-K — 2026-01-05
- 6-K — 2025-12-30
Latest PRE news
- — CAMTEK PRE-ANNOUNCES RECORD Q3 REVENUES ABOVE GUIDANCE; PROVIDES RECORD Q4 GUIDANCE AND INITIAL REVENUE OUTLOOK FOR 2027 (prnewswire.com)
- — SPECTRUM COMMUNITY SOLUTIONS TO BRING PRE-INSTALLED INTERNET AND WIFI TO SILVERWOOD'S NEW COMMUNITY, SILVERWOOD, IN HESPERIA, CALIF. (prnewswire.com)
- — Is Prenetics Global Ltd (PRE) a Bargain After 8.1% Drop? GF Value Says Undervalued (gurufocus.com)
- — U.S. VEHICLE SALES UNLIKELY TO REGAIN PRE-PANDEMIC LEVELS THIS DECADE, MOBILITY GLOBAL FORECAST SHOWS (prnewswire.com)
- — Prenetics Global Limited (NASDAQ:PRE) Receives Consensus Recommendation of “Moderate Buy” from Analysts
Educational tool only — not investment advice.